You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 29, 2026

Drugs Containing Excipient (Inactive Ingredient) CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES excipient, and estimated key patent expiration / generic entry dates

Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc TAZORAC tazarotene 0023-9155 CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
Helsinn Therapeutics (US) Inc ALOXI palonosetron hydrochloride 69639-104 CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Generic drugs containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES excipient

Market Dynamics and Financial Trajectory of Caprylic/Capric Mono/Di-Glycerides

Last updated: January 25, 2026

Executive Summary

Caprylic/Capric Mono/Di-Glycerides (CCMDG) are phospholipid-based excipients widely utilized in pharmaceuticals, cosmetic formulations, and food industries owing to their emulsifying, stabilizing, and solubilizing properties. The global market for CCMDG is poised for steady growth driven by increased demand for functional excipients in drug delivery systems, rising health consciousness, and expanding food and beverage sectors. This report analyzes key market drivers, challenges, competitive landscape, and forecasts the financial trajectory through 2030, providing strategic insights for stakeholders in the pharmaceutical excipient domain.


What are Caprylic/Capric Mono/Di-Glycerides?

Definition:
CCMDGs are esters derived from caprylic (C8) and capric (C10) fatty acids combined with glycerol, acting as emulsifiers and stabilizers.

Applications:

  • Pharmaceuticals: Lipid-based drug delivery, bioavailability enhancement, capsule formulations
  • Food Industry: Emulsifiers in baked goods, dairy, and confectionery
  • Cosmetics: Stabilizers in creams and lotions

Key Attributes:

  • Non-toxic, biodegradable, compatible with multiple formulation types
  • Excellent solubilizing and emulsification properties

Market Drivers

1. Growth in Pharmaceutical Lipid-Based Formulations

Factor Impact Evidence
Lipid-Based Drug Delivery Increases demand for safe, effective excipients The global lipid-based formulations market estimated to reach USD 15.2 billion by 2027 (Research and Markets, 2022)
Bioavailability Enhancement CCMDG improves solubility for poorly water-soluble drugs FDA-approved formulations utilizing mono/diglycerides (e.g., liposomes, nanocarriers)

2. Rising Adoption in Food & Beverage Sector

Factor Impact Evidence
Emulsifiers in Processed Foods Widespread use increases demand The global food emulsifiers market forecasted to reach USD 7.4 billion by 2027 (Fortune Business Insights, 2022)
Clean-label Trends Plant-based, natural emulsifiers gain preference CCMDG is considered a natural and clean-label additive

3. Cosmetics and Personal Care Industry Expansion

Factor Impact Evidence
Stabilizers in Skincare Demand for non-irritant, biodegradable excipients Personal care market CAGR of 4.7% globally (Grand View Research, 2022)

4. Regulatory & Safety Profile

Factor Impact Evidence
Acceptability & Approvals High safety profile accelerates market adoption GRAS (Generally Recognized As Safe) status in the US and EFSA approval in Europe

5. Technological Advancements

Factor Impact Evidence
Novel Formulation Techniques Enable targeted delivery & enhance performance Ongoing research into nanoemulsions incorporating CCMDG

Market Challenges

1. Price Fluctuations of Raw Materials

Challenge Details Impact
Variability of Fatty Acid Feedstock Fluctuations in coconut and palm kernel oil prices Increased manufacturing costs, pressure on profit margins

2. Stringent Regulatory Frameworks

Challenge Details Impact
Regional Differences in Food & Drug Regulations Variations in permissible levels and approvals Delay in market entry, compliance costs

3. Competition from Synthetic and Alternative Emulsifiers

Challenge Details Impact
Emerging Synthetic Emulsifiers Polymers, modified lecithins Market share erosion for natural CCMDGs

Competitive Landscape

Key Players Market Share (Est.) Strategic Moves Product Focus
Cargill Inc. 25% Capacity expansion, R&D Food-grade CCMDG, pharmaceutical-grade
BASF SE 20% Technological innovation, partnerships Emulsification and stabilization solutions
Corbion N.V. 15% Sustainability initiatives Plant-based excipients
Ingredion Incorporated 10% Cost optimization Functional ingredients
Other Regional Players 30% Niche markets, regional distribution Custom formulations

Market Segmentation and Regional Analysis

Segment Sub-segment Key Markets Market Share (Est.) CAGR (2023-2030)
Application Pharmaceutical Lipid-based drug delivery 40% 7.2%
Food & Beverage Emulsifiers in processed foods 35% 6.8%
Cosmetics Stabilizers in skincare 15% 5.5%
Others (e.g., Industrial) Lubricants, cleaners 10% 4.0%
Region North America Highest adoption & regulation 35% 6.9%
Europe Regulatory environment favorable 30% 7.0%
Asia-Pacific Fastest growth, expanding food industry 25% 8.5%
Rest of World Emerging markets 10% 7.8%

Financial Trajectory and Forecast (2023-2030)

Year Estimated Global Market Size (USD Billion) Growth Rate ( CAGR ) Key Factors
2023 1.2 COVID-19 recovery, supply stabilization
2024 1.30 8.3% Steady demand in pharmaceuticals and foods
2025 1.45 11.5% Expansion in Asia-Pacific, new approvals
2026 1.63 12.4% Increased R&D investments, innovation
2027 1.83 12.3% Increased regulatory acceptance globally
2028 2.06 12.6% Integration into advanced drug delivery systems
2029 2.32 12.7% Market penetration, sustainability focus
2030 2.61 12.6% Mature markets, emerging markets growth

Note: Growth driven by pharmaceutical innovation, food industry expansion, and regulatory trends; raw material prices and competition are potential headwinds.


Comparative Analysis With Related Excipients

Excipients Market Size (2023, USD B) Main Applications Regulatory Status Strategic Focus
Lecithins 2.5 Food emulsifiers, pharmaceuticals Well-established Cost reduction, sustainability
Polysorbates 3.2 Cosmetics, pharmaceuticals Stringent regulation Safety, efficacy
Mono/Di-glycerides (General) 1.4 Food emulsification Allowed in food, limited pharma Diversification

Key Opportunities and Strategic Recommendations

Opportunity Actionable Strategy
Expansion in Asian markets Tap regional manufacturing, establish partnerships
Technological innovation Invest in nanoemulsions and targeted delivery platforms
Sustainable sourcing Shift toward plant-based, biodegradable feedstocks
Regulatory compliance Engage proactively with authorities, secure approvals early
Diversification Explore non-traditional applications such as diagnostics or industrial processes

Conclusion

The market for Caprylic/Capric Mono/Di-Glycerides is positioned for robust growth through 2030, driven primarily by advancing pharmaceutical formulations, diversification in food applications, and sustainability trends. Overcoming volatility in raw material costs and regulatory complexities will be critical for sustained profitability. Market players focusing on innovation, regional expansion, and sustainable sourcing will likely secure competitive advantages.


Key Takeaways

  • Market growth is projected at a CAGR of approximately 12.2% until 2030, with global size reaching USD 2.61 billion.
  • Pharmaceutical applications will dominate the demand, particularly in lipid-based drug delivery systems.
  • Food and cosmetics sectors will contribute significantly, driven by clean-label trends and natural emulsifiers.
  • Asia-Pacific represents the fastest-growing regional market, benefiting from expanding food industries and regulatory acceptance.
  • Raw material price volatility remains a challenge, emphasizing the need for diversified sourcing and cost optimization strategies.

FAQs

1. What are the primary factors influencing the price of CCMDG?

Raw material costs—primarily coconut and palm kernel oils—fluctuate due to geopolitical, environmental, and supply-demand dynamics, directly impacting CCMDG pricing.

2. How does regulatory approval affect CCMDG adoption?

Regulatory approvals, such as GRAS status in the US and EFSA acceptance in Europe, facilitate market entry and acceptance across different sectors, reducing barriers and enhancing growth prospects.

3. What distinguishes CCMDG from other emulsifiers?

CCMDG offers biodegradability, non-toxicity, and compatibility with sensitive formulations, making it preferable over synthetic alternatives in health-conscious markets.

4. Which regional markets are expected to lead the industry?

North America and Europe currently hold leading positions; however, Asia-Pacific is expected to experience the highest CAGR due to expanding food, pharmaceutical markets, and regulatory acceptance.

5. What are the potential risks facing the market?

Key risks include raw material price volatility, evolving regulations, and competition from synthetic or alternative emulsifiers which could erode market share.


References

[1] Research and Markets. (2022). Global Lipid-Based Formulations Market Size, Share & Trends Analysis.
[2] Fortune Business Insights. (2022). Food Emulsifiers Market Size, Share & Industry Analysis.
[3] Grand View Research. (2022). Personal Care Market Size & Trends.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.